Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2025-10-17 00:00:00 ET · period of report 2025-10-15 · accession 0001214659-25-015048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-17 | 2025-10-15 | AQST | Jung Cassie | COO | S - Sale+OE | $7.01 | -67.6K | 240.8K | -22% | -$473.7K |
| D | 2025-10-17 | 2025-10-15 | AQST | Jung Cassie | COO | M - OptEx | $3.10 | +25.0K | 308.3K | +9% | +$77.5K |
| D | 2025-10-17 | 2025-10-15 | AQST | Jung Cassie | COO | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-15 | S | D | 67,575 | $7.01 | 240,771 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-15 | M | A | 25,000 | $3.10 | 308,346 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-15 | M | D | 25,000 | $0.00 | 0 | D | $3.10 · — to 2031-06-10 | 25,000 Common Stock | (F3) This option was granted on June 10, 2021 and is fully vested. |